About 26S proteasome regulatory subunit 7
26S proteasome regulatory subunit 7 (PSMC2) is a protein
from Homo sapiens identified by UniProt accession
P35998, 433 residues long.
MolForge cross-references it against 0 known binders and
92 disease associations.
Target properties
| Protein name | 26S proteasome regulatory subunit 7 |
| UniProt accession | P35998 |
| Gene | PSMC2 |
| Organism | Homo sapiens |
| Length | 433 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (92)
Diseases linked to this target (Open Targets).
- HIV infection · score 0.46
- lung adenocarcinoma · score 0.29
- endometrial cancer · score 0.29
- head and neck squamous cell carcinoma · score 0.29
- urinary bladder cancer · score 0.28
- squamous cell lung carcinoma · score 0.28
- gastric adenocarcinoma · score 0.27
- multiple myeloma · score 0.24
- hepatocellular carcinoma · score 0.20
- neurodegenerative disease · score 0.17
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P35998-F1 | alphafold | PREDICTED | 80.53 | — |
Amino-acid sequence (433 residues)
MPDYLGADQR KTKEDEKDDK PIRALDEGDI ALLKTYGQST YSRQIKQVED DIQQLLKKIN ELTGIKESDT GLAPPALWDL AADKQTLQSE QPLQVARCTK IINADSEDPK YIINVKQFAK FVVDLSDQVA PTDIEEGMRV GVDRNKYQIH IPLPPKIDPT VTMMQVEEKP DVTYSDVGGC KEQIEKLREV VETPLLHPER FVNLGIEPPK GVLLFGPPGT GKTLCARAVA NRTDACFIRV IGSELVQKYV GEGARMVREL FEMARTKKAC LIFFDEIDAI GGARFDDGAG GDNEVQRTML ELINQLDGFD PRGNIKVLMA TNRPDTLDPA LMRPGRLDRK IEFSLPDLEG RTHIFKIHAR SMSVERDIRF ELLARLCPNS TGAEIRSVCT EAGMFAIRAR RKIATEKDFL EAVNKVIKSY AKFSATPRYM TYN
Explore 26S proteasome regulatory subunit 7 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets